Loading clinical trials...
Loading clinical trials...
Safety and Efficacy of the Addition of Simvastatin to Panitumumab in K-ras Mutant Advanced or Metastatic Colorectal Cancer Patients. A Single-Arm, Multicenter, Phase II Study Using a Simon Two Stage Design.
Conditions
Interventions
panitumumab
simvastatin
+1 more
Locations
4
Netherlands
Reinier de Graaf Group - Delft
Delft, Netherlands
Leiden University Medical Center
Leiden, Netherlands
Diaconessenhuis Leiden
Leiden, Netherlands
HagaZiekenhuis - Locatie Leyenburg
The Hague, Netherlands
Start Date
April 1, 2010
Primary Completion Date
April 1, 2012
Last Updated
September 17, 2013
NCT04704661
NCT06696768
NCT05489211
NCT06625775
NCT04657068
NCT06445062
Lead Sponsor
Leiden University Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions